CAS 7632-00-0 MFCD00011118-Sodium nitrite, 99%, AR 亚硝酸钠 TAO{mole}

Sodium nitrite, 99%, AR 亚硝酸钠

CAS 7632-00-0 MFCD00011118

化学结构图

SMILES: O=N[O-].[Na+]

化学属性

Mol. Formula	N O2 . Na
Mol. Weight	69
Melting Point	271
Density	2.17
TSCA	Yes
Solubility	Soluble in water
Autoignition Point	914 °F
Boiling Point
Stability	对湿度敏感
Appearance	powder
Flash Point	-

别名和识别编码

Chemical Name	Sodium nitrite, 99%, AR
MDL Number	MFCD00011118
CAS Number	7632-00-0
PubChem Substance ID	23668193
EC Number	231-555-9
Merck Number	8648
Synonym	Nitrite, Sodium Nitrous acid (sodium salt) Sodium Nitrite {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} { {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {}
Beilstein Registry Number	2384789
Chemical Name Translation	亚硝酸钠
Reaxys-RN	906771
Wiswesser Line Notation	NA N-O-O
LabNetwork Molecule ID	LN00194028
InChI	InChI=1S/HNO2.Na/c2-1-3;/h(H,2,3);/q;+1/p-1
Canonical SMILES	O=NO[Na]

信息真实价格透明资金保障专业采购外包团队在线服务

品牌质保精细包装现货库存一流品牌服务

产品应用

用于ICP-AES、AAS、AFS、ICP-MS、离子色谱等。滴定分析用标准溶液。校准仪器和装置；评价方法；工作标准；质量保证/质量控制；其他

安全信息

Personal Protective Equipment Eyeshields, Faceshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter Eyeshields, Gloves Eyeshields, Gloves, half-mask respirator (US), multi-purpose combination respirator cartridge (US)

WGK Germany3

Hazard Codes 5.1

GHS Symbol

Precautionary statements

P321 Specific treatment (see … on this label). 具体治疗（见本标签上的）。
P405 Store locked up. 上锁保管。
P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西，喝水或吸烟。
P220 Keep/Store away from clothing/…/combustible materials. 保持远离/贮存远离服装/....../可燃材料。
P501 Dispose of contents/container to..… 处理内容物/容器.....
P337+P317
P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
P305+P351+P338
P210 Keep away from heat/sparks/open flames/hot surfaces. — No smoking. 远离热源/火花/明火/热的表面。——禁止吸烟。
P301+P316
P370+P378
P273 Avoid release to the environment. 避免释放到环境中。
P330 Rinse mouth. 漱口
P264+P265
P391 Collect spillage. Hazardous to the aquatic environment 收集对水环境有危害的泄漏物。

Hazard statements

H272 May intensify fire; oxidizer 可能加剧火势；氧化剂。
H301 Toxic if swallowed 吞食有毒
H302 Harmful if swallowed 吞食有害
H319 Causes serious eye irritation 严重刺激眼睛
H400 Verytoxictoaquaticlife 对水生生物毒性非常大。

Signal word Danger

RTECSRA1225000

Safety Statements

S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时，立即求医（可能时出示标签）；
S36 Wear suitable protective clothing 穿戴适当的防护服；
S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后，立即用大量水冲洗并征求医生意见；
S61 Avoid release to the environment. Refer to special instructions/safety data sheet 避免释放到环境中，参考特别指示/安全收据说明书；

UN Number 1500

Risk Statements

R8 Contact with combustible material may cause fire 遇到易燃物会导致起火
R50 Very toxic to aquatic organisms 对水生生物极毒
R25 Toxic if swallowed 吞咽有毒
R36/38 Irritating to eyes and skin 对眼睛和皮肤有刺激性
R22 Harmful if swallowed 吞咽有害

Storage condition +20°C 20 20℃ Store at room temperature {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {}

Packing GroupIII

Hazard Class5.1/6.1

Warnings 危化品目录(2015)

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 2149 mg/kg
                          male 2 week(s) pre-mating
                          female 2 week(s) pre-mating  - 3 week(s) post-birth
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criteria
   Reproductive - Tumorigenic effects - transplacental tumorigenesis
   Lungs, Thorax, or Respiration - tumors
REFERENCE :
   CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
   Sts., Philadelphia, PA 19106)  V.1-    1941-  Volume(issue)/page/year:
   45,3561,1985

TYPE OF TEST            : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 63 gm/kg/95W-C
TOXIC EFFECTS :
   Tumorigenic - equivocal tumorigenic agent by RTECS criteria
   Gastrointestinal - tumors
REFERENCE :
   JJIND8 JNCI, Journal of the National Cancer Institute.  (Washington, DC)
   V.61-79, 1978-87. For publisher information, see JNCIEQ.
   Volume(issue)/page/year: 64,1435,1980

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 2190 gm/kg/2Y-C
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criteria
   Gastrointestinal - tumors
REFERENCE :
   HKXUDL Huanjing Kexue Xuebao.  Environmental Sciences Journal.  (China
   International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 
     1981-  Volume(issue)/page/year: 6,246,1986

TYPE OF TEST            : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 100 gm/kg/2Y-I
TOXIC EFFECTS :
   Tumorigenic - neoplastic by RTECS criteria
   Liver - tumors
REFERENCE :
   CRNGDP Carcinogenesis (London).

TYPE OF TEST            : LDL

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 65 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.)  V.1-    1951-
   Volume(issue)/page/year: 13,320,1963

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Human - man
DOSE/DURATION           : 1714 ug/kg/70M
TOXIC EFFECTS :
   Cardiac - pulse rate increase, without fall in BP
   Vascular - BP lowering not characterized in autonomic section
REFERENCE :
   JCINAO Journal of Clinical Investigation.  (Rockefeller Univ. Press, 1230
   York Ave., New York, NY 10021)  V.1-    1924-  Volume(issue)/page/year:
   16,73,1937

{haz

TYPE OF TEST            : LDLo - Lowest published

TYPE OF TEST            : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Mammal - dog
DOSE/DURATION           : 330 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   27ZIAQ "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes,
   C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973
   Volume(issue)/page/year: -,245,1973

TYPE OF TEST            : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Mammal - cat
DOSE/DURATION           : 1500 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   HBAMAK "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig,
   Ger. Dem. Rep.)  Volume(issue)/page/year: 4,1372,1935

TYPE OF TEST            : Mutation test systems - not otherwise specified
TEST SYSTEM             : Bacteria - Salmonella typhimurium
DOSE/DURATION           : 2200 mg/L
REFERENCE :
   MUREAV Mutation Research.  (Elsevier Science Pub. B.V., POB 211, 1000 AE
   Amsterdam, Netherlands) V.1-    1964-  Volume(issue)/page/year: 192,239,1987

TYPE OF TEST            : Mutation in microorganisms
TEST SYSTEM             : Bacteria - Salmonella typhimurium
DOSE/DURATION           : 1 mg/plate
REFERENCE :
   MIBUBI Mikrobiyoloji Bulteni.  Bulletin of Microbiology.  (c/o Dr. A. Tevfik
   Cenqiz, Ankara Universitesi Tip Fakultesi Mikrobiyoloji Ana B

TYPE OF TEST            : Mutation in microorganisms
TEST SYSTEM             : Bacteria - Salmonella typhimurium
DOSE/DURATION           : 250 ug/plate
REFERENCE :
   MUREAV Mutation Research.  (Elsevier Science Pub. B.V., POB 211, 1000 AE
   Amsterdam, Netherlands) V.1-    1964-  Volume(issue)/page/year: 28,31,1975

TYPE OF TEST            : DNA repair
TEST SYSTEM             : Bacteria - Escherichia coli
DOSE/DURATION           : 625 ug/well
REFERENCE :
   MUREAV Mutation Research.  (Elsevier Science Pub. B.V., POB 211, 1000 AE
   Amsterdam, Netherlands) V.1-    1964-  Volume(issue)/page/year: 133,161,1984

TYPE OF TEST            : Mutation in microorganisms
TEST SYSTEM             : Microorganism - not otherwise specified
DOSE/DURATION           : 5 mol/L
REFERENCE :
   MGGEAE Molecular and General Genetics.  (Springer-Verlag, Heidelberger Pl.
   3, D-1000 Berlin 33, Fed. Rep. Ger.)  V.99-    1967-
   Volume(issue)/page/year: 141,207,1975

TYPE OF TEST            : Sister chromatid exchange
TEST SYSTEM             : Rodent - hamster Fibroblast
DOSE/DURATION           : 3 mmol/L
REFERENCE :
   PJACAW Proceedings of the Japan Academy.  (Tokyo, Japan)  V.21-53, 1945-77.
   For publisher information, see PJABDW.  Volume(i

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 10280 mg/kg
SEX/DURATION            : female 1-22 day(s) after conception
                          lactating female 20 day(s) post-birth
TOXIC EFFECTS :
   Reproductive - Effects on Newborn - weaning or lactation index (e.g., #
   alive at weaning per # alive at day 4)
REFERENCE :
   FAATDF Fundamental and Applied Toxicology.  (Academic Press, Inc., 1 E.
   First St., Duluth, MN 55802) V.1-    1981-  Volume(issue)/page/year:
   9,668,1987

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 1200 mg/kg
SEX/DURATION            : female 6-15 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - pre-implantation mortality (e.g. reduction in
   number of implants per female; total number of implants per corpora lutea)
   Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
   NEZAAQ Nippon Eiseigaku Zasshi.  Japanese Journal of Hygiene.  (Nippon Eisei
   Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606,
   Japan)  V.1-    1946-  Volume(issue)/page/year: 42,836,1987

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 400 mg/kg
SEX/DURATION            : female 10-19 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - Central Nervous System
   Reproductive - Specific Developmental Abnormalities - blood and lymphatic
   systems (including spleen and marrow)
   Reproductive - Effects on Newborn - behavioral
REFERENCE :
   ZVNDAM Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I. P. Pavlova.
   (Izdatelstvo Nauka, 21 Garibaldi Street

Restrict 危险品

其他信息

类别:氧化剂
图谱信息:亚硝酸钠(7632-00-0)红外图谱(IR1)
用途四:用作普通分析试剂、氧化剂和重氮化试剂，还用于亚硝酸盐和亚硝基化合物的合成
用途二:用作
亚硝酸钠价格(试剂级):更新日期产品编号产品名称包装价格 2011/08/23 10020090 亚硝酸钠 250g 152元 2011/08/23 10020018 亚硝酸钠 500g 14元 2011/08/23 10020028 亚硝酸钠 500g 13元
毒性分级:高毒
使用限量:GB 2760-1996(g/kg)：腌制畜、禽肉类罐头、肉制品，0.15；腌制盐水火腿残留量0.07。
含量分析:GB 1907-92法 1+5、1+29无还原性硫酸的制备按照比例将硫酸加至水中，混匀后加热至70℃左右，滴加0.1mol/L高锰酸钾溶液，至溶液呈微红色为止，冷却后即可使用。 0.1mol/L草酸钠溶液的配制取草酸钠6.7g，溶于“1+29克还原性硫酸”300ml中，用水定容至1000ml。测定手续取试样2.5～2.7g(称准至0.0002g)，溶于水后，移入500ml容量瓶中，用水定容并混匀。经滴定管将40ml 0.1mol/L高锰酸钾溶液加于300ml锥形瓶中，用移液管移人试样液25ml，再加10ml无还原性硫酸溶液，将溶液加热至40℃，经移液管加入0.1 mol/L草酸钠溶液10ml，加热至70～80℃，再用0.1mol/L高锰酸钾溶液滴定至呈微红色并保持半分钟不消失。式中 c——高锰酸钾标准溶液的浓度，mol/L； V——加入和滴定用KMnO 4 标准溶液的总体积，ml； c 1 ——草酸钠标准溶液的浓度，mol/L； V 1 ——草酸钠标准溶液的体积，ml； G一试样质量，g； x——按本标准测得的干燥失重含量，%； 0.0345——亚硝酸钠的毫摩尔质量，g。 FAO/WHO(1995)法取在硅胶上预经干燥4h后的试样1g(称准至mg)。移入100ml容量瓶，用水定容。吸取该液10.0ml，移入由0.1mol/L高锰酸钾50.0ml、水100ml和硫酸5ml组成的混合液中，温热至40℃，静置5min，加0.1mol/L草酸25.0ml。将混合液加热至约80℃，用0.1mol
易溶于水，微溶于醇及醚。有吸湿性。加热至320℃以上分解。在空气中慢慢氧化为硝酸钠，遇弱酸分解放出棕色三氧化二氮气体。溶于1.5份冷水、0.6份沸水，水溶液呈碱性，pH约9。
所属类别一:无机化工产品: 无机盐: Cl硝酸盐
用途九:用作媒染剂、漂白剂、金属热处理剂、电镀缓蚀剂，医药上用作器械消毒、防腐剂。
下游产品:2-氟-6-甲基吡啶 --> 2,6-二甲基-4-羟基吡啶 --> 6-氟烟酸 --> 4-氧代-1,4-二氢-2,6-吡啶二甲酸 --> 5-(4-溴苯基)-2-呋喃甲醛 --> 中文名称暂缺 --> (S)-(+)-2-羟基-3-甲基丁酸 --> 直接耐晒黑G --> 碱性橙 --> 3-氯-5-硝基-1H-吲唑 --> 4-碘吡啶 --> 2-羟基-4-吡啶醛 --> 5-氨基吲唑 --> 3-溴-6-硝基吲唑 --> 2-溴-5-硝基噻唑 --> 5-ó4-氟-3-(三氟甲烷)-2-糠醛 --> 6-羟基吲唑 --> 2-氟-5-甲基吡啶 --> 7-硝基吲唑 --> 活性红15 --> 媒介黑 9 --> 1,3-二甲氧基-5-氟苯 --> 4-氟三氟甲苯 --> 颜料黄 14 --> 4-(N,N-二乙基)-2-甲基苯二胺盐酸盐 --> 颜料红 146 --> 4-(N-乙基-N-羟乙基)-2-甲基苯二胺硫酸盐 --> 1-甲基-4-乙氧基羰基吡唑-5-磺酰胺 --> 吲唑-3-羧酸乙脂 --> 6-硝基吲唑 --> 硝基丙二醛钠·一水合物 --> 3-氟三氟甲苯 --> 苯并三氮唑钠
方法一:使氨气氧化产生氧化氮气体，用氢氧化钠或碳酸钠溶液吸收。用铅还原硝酸钠，加热熔化硝酸钠，加少量金属铅，搅拌并继续加热至铅全部氧化。生成的块状物边冷却边分成小块，用热水萃取生成的氧化铅数次。通入二氧化碳气体使生成碳酸铅沉淀，经过滤，用稀硝酸准确中和滤液后，蒸发、浓缩析出亚硝酸钠结晶。经吸滤，用乙醇洗涤后干燥，再重结晶精制而得。
{Chemic